Filtered By:
Condition: Hypertension
Procedure: Percutaneous Coronary Intervention

This page shows you your search results in order of date. This is page number 9.

Order by Relevance | Date

Total 148 results found since Jan 2013.

Outcomes in hypertensive crisis as predicted by red cell distribution width
Red cell distribution width (RDW) is a measure of the variability in size of erythrocytes. A high RDW value indicates greater variation in size between individual erythrocytes and has been shown to be an independent predictor of mortality in patients with coronary artery disease, heart failure, acute stroke and in patients undergoing percutaneous coronary intervention (PCI). The aim of this study was to evaluate the prognostic value of RDW in predicting clinical outcomes in patients with hypertensive crisis.
Source: Journal of the American Society of Hypertension - March 31, 2016 Category: Cardiology Authors: Fawad Virk, Ruchir Patel, Sagger Mawri, Suraj Raheja, Ayush Motwani, James McCord Tags: Epidemiology/Special Populations Source Type: research

Determinants of Mortality in Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention
In this study we included 293 consecutive patients with CKD who underwent PCI between 1st January 2007 and 30th September 2012. The primary outcome that we studied was all-cause mortality in a follow-up period of 12-69 months (mean 38.8 ± 21.7). Results: Age (p
Source: Cardiorenal Medicine - February 19, 2016 Category: Urology & Nephrology Source Type: research

Gene mutations of platelet glycoproteins and response to tirofiban in acute coronary syndrome.
CONCLUSIONS: Mutations of glycoproteins Ia, Ib, IIb and IIIa did not influence platelet aggregation in response to tirofiban in patients with unstable angina and non-ST-segment elevation myocardial infarction. PMID: 26786608 [PubMed - as supplied by publisher]
Source: Sao Paulo Medical Journal - January 19, 2016 Category: Journals (General) Authors: Mansur AP, Roggerio A, Takada JY, Caribé PM, Avakian SD, Strunz CM Tags: Sao Paulo Med J Source Type: research

Non-eligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR)
Conclusion Most patients with STEMI not receiving reperfusion therapy had a documented reason. Coronary anatomy not suitable for PCI was the major contributor to ineligibility. In-hospital mortality was higher in patients not receiving reperfusion therapy.
Source: American Heart Journal - January 12, 2016 Category: Cardiology Source Type: research

Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy Coronary Heart Disease
Conclusions Our analysis suggests that the CRUSADE score predicts major bleeding similarly to ACUITY and better than HAS BLED in an all-comer population with percutaneous coronary intervention and potentially identifies patients at higher risk of hemorrhagic complications when treated with a long-term dual antiplatelet therapy regimen. Clinical Trial Registration URL: http://clinicaltrials.gov. Unique identifier: NCT00611286.
Source: JAHA:Journal of the American Heart Association - December 7, 2015 Category: Cardiology Authors: Costa, F., Tijssen, J. G., Ariotti, S., Giatti, S., Moscarella, E., Guastaroba, P., De Palma, R., Ando, G., Oreto, G., Zijlstra, F., Valgimigli, M. Tags: Coronary Heart Disease Source Type: research

None-ligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR)
Conclusion Most patients with STEMI not receiving reperfusion therapy had a documented reason. Coronary anatomy not suitable for PCI was the major contributor to ineligibility. In-hospital mortality was higher in patients not receiving reperfusion therapy.
Source: American Heart Journal - November 25, 2015 Category: Cardiology Source Type: research

Comparison of Clinical Outcomes Following Single versus Multivessel Percutaneous Coronary Intervention Using Biodegradable Polymer Coated Sirolimus-Eluting Stent in an All-comers Patient Population.
CONCLUSION: Our study shows that use of the Supraflex SES in single and multivessel coronary artery disease produces good clinical outcomes during 12 months of follow-up with a low rate of revascularization, despite complex lesion morphology. PMID: 26585397 [PubMed - as supplied by publisher]
Source: Cardiovascular and Hematological Agents in Medicinal Chemistry - November 21, 2015 Category: Cardiology Tags: Cardiovasc Hematol Agents Med Chem Source Type: research

Insufficient platelet inhibition and thromboembolic complications in patients with intracranial aneurysms after stent placement.
CONCLUSIONS The ADP inhibition percentage is related to thromboembolic complications after stent placement for intracranial aneurysms. The increase of the ADP inhibition may decrease the risk of thromboembolic complications. PMID: 26587657 [PubMed - as supplied by publisher]
Source: Journal of Neurosurgery - November 20, 2015 Category: Neurosurgery Authors: Yang H, Li Y, Jiang Y Tags: J Neurosurg Source Type: research

Abstract 090: Outcomes of Hypertensive Crises as Predicted by Red Cell Distribution Width Session Title: Concurrent XV C: Clinical Hypertension
Conclusions: Elevated RDW level in patients with hypertensive crisis was an independent predictor of all-cause mortality and new-onset heart failure in patients with hypertensive crisis.
Source: Hypertension - November 3, 2015 Category: Cardiology Authors: Raheja, S., Patel, K., Patel, R., Mawri, S., Michaels, A., Gibbs, J., McCord, J. Tags: Session Title: Concurrent XV C: Clinical Hypertension Source Type: research

Heart rate and use of β-blockers in Mexican stable outpatients with coronary artery disease.
CONCLUSIONS: In a large proportion of Mexican patients with stable coronary disease the HR remain elevated, >70bpm, even with the use of β-blockers; this requires further attention. PMID: 25921309 [PubMed - as supplied by publisher]
Source: Archivos de Cardiologia de Mexico - April 24, 2015 Category: Cardiology Authors: Alcocer-Gamba MA, Martínez-Sánchez C, Verdejo-Paris J, Ferrari R, Fox K, Greenlaw N, Steg Philippe G, por los investigadores CLARIFY Tags: Arch Cardiol Mex Source Type: research

A Meta‐Analysis of Sex‐Related Differences in Outcomes After Primary Percutaneous Intervention for ST‐Segment Elevation Myocardial Infarction
ConclusionsAs compared to men, women undergoing pPCI have more bleedings and strokes, and a worse early, but not mid‐term mortality. These findings may allow a better risk stratification of pPCI patients.
Source: Journal of Interventional Cardiology - April 17, 2015 Category: Cardiology Authors: FEDERICO CONROTTO, FABRIZIO D'ASCENZO, KARIN H HUMPHRIES, JOHN G WEBB, PAOLO SCACCIATELLA, COSTANZA GRASSO, MAURIZIO D'AMICO, GIUSEPPE BIONDI‐ZOCCAI, FIORENZO GAITA, SEBASTIANO MARRA Tags: Original Investigation Source Type: research

First‐in‐Man Study of Dedicated Bifurcation Sirolimus‐eluting Stent: 12‐month Results of BiOSS LIM® Registry
ConclusionDedicated bifurcation stent BiOSS® LIM proved to be feasible device, with promising safety and long‐term clinical effectiveness in the treatment of coronary bifurcation lesions, including distal left main stem stenosis. (J Interven Cardiol 2015;28:51–60)
Source: Journal of Interventional Cardiology - February 16, 2015 Category: Cardiology Authors: ROBERT J. GIL, JACEK BIL, DOBRIN VASSILIEV, LUIS A. IÑIGO GARCIA Tags: Original Investigation Source Type: research

0120: B-type Nt-proBNP as a marker for contrast induced nephropathy in patients with primary percutaneous coronary intervention for ST segment elevation myocardial infarction
Conclusion From this large contemporary prospective study, our work suggests that Nt-proBNP levels at admission could help to identify patients at risk of CIN beyond traditional risk factors.
Source: Archives of Cardiovascular Diseases Supplements - February 12, 2015 Category: Cardiology Source Type: research

Particularities in coronary revascularization in elderly patients presenting with ST segment elevation acute myocardial infarction (STEMI)
Publication date: August 2014 Source:Cor et Vasa, Volume 56, Issue 4 Author(s): Maria Dorobanţu , Lucian Câlmâc , Andrada Bogdan , Vlad Bătăilă , Bogdan Drăgoescu , Andrei Radu , Mugur Marinescu , Şerban Arvanitopol , Gabriel Tatu-Chiţoiu , Rodica Niculescu Nowadays, ST elevation acute myocardial infarction (STEMI) is seen with greater incidence in older patients. Current guidelines recommend an immediate invasive evaluation and eventually primary percutaneous coronary intervention (PCI) in all STEMI patients regardless of age. Nevertheless, data in literature show a significant underuse of interventional treatm...
Source: Cor et Vasa - November 1, 2014 Category: Cardiology Source Type: research

Triple Therapy for Atrial Fibrillation and Percutaneous Coronary Intervention A Contemporary Review
Chronic oral anticoagulant therapy is recommended (class I) in patients with mechanical heart valves and in patients with atrial fibrillation with a CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, prior Stroke or transient ischemic attack or thromboembolism, Vascular disease, Age 65 to 74 years, Sex category) score ≥1. When these patients undergo percutaneous coronary intervention with stenting, treatment with aspirin and a P2Y12 receptor inhibitor also becomes indicated. Before 2014, guidelines recommended the use of triple therapy (vitamin K antagonists, aspirin, and clopidog...
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - September 15, 2014 Category: Cardiology Source Type: research